gms | German Medical Science

88th Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

24.05. - 27.05.2017, Erfurt

Article

Send article

Expression of basic Fibroblast Growth Factor in acquired cholesteatoma and correlation with its destructive capacity

Meeting Abstract

Search Medline for

  • corresponding author Mahmood Hamed - Sohag University, Sohag, Egypt, Sohag, EGYPT
  • Seiichi Nakata - Otolaryngolgy Department, Fujita Health University School of Medicine, Second af, Nagoya, Japan
  • Kazuya Shiogama - Pathology Department, Fujita Health University School of Medicine, Toyoake, Japan
  • Ramadan Sayed - Otolaryngolgy Department, Sohag faculty of Medicine, Sohag University Hospital, Sohag, Egypt
  • Yutaka Tsutsumi - Pathology Department, Fujita Health University School of Medicine, Toyoake, Japan

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. 88. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. Erfurt, 24.-27.05.2017. Düsseldorf: German Medical Science GMS Publishing House; 2017. Doc17hno286

doi: 10.3205/17hno286, urn:nbn:de:0183-17hno2868

Published: April 13, 2017

© 2017 Hamed et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.

Outline

Text

Introduction: Angiogenesis is an essential requirement for cholesteatoma growth and expansion. It is mediated via variety of cytokines and growth factors like basic fibroblast growth factor (basic-FGF). Localization of basic FGF in cholesteatoma matrix and its correlation with the destructive capacity of cholesteatoma were seldom seen in previous reports.

Methodology: A prospective immunohistochemical study was employed using 19 acquired cholesteatoma tissues collected during surgery and 8 control tissues from the skin of the deep portion of the external auditory canal. Cholesteatoma patients were categorized into two groups according to their bone destructive capacity following a newly developed scoring system (invasive and non-invasive group). The expression pattern was determined more specifically by the immune absorption test and compared. Moreover, this expression was correlated with the grading score for bone resorption.

Results: Basic FGF was localized in the parabasal and to lesser extent in the basal keratinocytes of cholesteatoma matrix. Highly significant difference was identified between cholesteatoma and skin tissues (Mean ± SEM= 58.53% ± 3.6 in cholesteatoma versus 40.6% ± 3.5 in the skin; P = 0.005). Although the mean expression in the invasive group was higher than non-invasive one, no significant difference between both groups was detected (P >0.05). In addition, no significant correlation between expression and degree of bone erosion.

Conclusion: Basic FGF is overexpressed in cholesteatoma tissue reflecting its vital role in cholesteatoma growth. However, its correlation with destructive potential of cholesteatoma remains questionable. Larger studies are needed to clarify this point which can affect the future management of cholesteatoma.

Der Erstautor gibt keinen Interessenkonflikt an.